SCHEMBL7149094

SCHEMBL7149094

Nc1nc(C=Cc2ccccc2)cc(-c2ccco2)n1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 5/20 0.55
HDAC6 Q9UBN7 1/20 0.50
ADORA2A P29274 6/20 0.46
ADORA1 P30542 5/20 0.46
ADORA2B P29275 4/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
ADORA3 P0DMS8 1/20 0.46
SMARCA2 P51531 1/20 0.43
PBRM1 Q86U86 1/20 0.43
MAPT P10636 1/20 0.42
HSD17B10 Q99714 1/20 0.42
DHFR P00374 1/20 0.42
PTGS1 P23219 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1554000 0.78 MAPT (0.58) ADORA2AADORA1ADORA2BKDM4EALDH1A1
SCHEMBL7146741 0.76 ADORA2A (0.43) GRM4ADORA2AADORA1ADORA2BALDH1A1
SCHEMBL29044796 0.74 MAPT (0.53) ADORA2AADORA1ADORA2BKDM4EALDH1A1
SCHEMBL30488014 0.74 MAPT (0.53) ADORA2AADORA1ADORA2BKDM4EALDH1A1
SCHEMBL28603596 0.74 GRM4 (0.70) GRM4HDAC6KDM4EALDH1A1HPGD
SCHEMBL30488038 0.74 GRM4 (0.70) GRM4HDAC6KDM4EALDH1A1HPGD
SCHEMBL718474 0.71 HSP90AA1 (0.54) ADORA2AADORA1ADORA2BKDM4EALDH1A1
SCHEMBL30353595 0.71 ADORA2A (0.50) ADORA2AADORA1ADORA2BKDM4EALDH1A1
SCHEMBL717572 0.71 MAPT (0.54) ADORA2AADORA1ADORA2BKDM4EALDH1A1
SCHEMBL30108078 0.71 MAPT (0.50) ADORA2AADORA1ADORA2BKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586441-B2 2-Amino-6-benzylsulfanyl-4-thiophen-2-yl-pyridine-3,5-dicarbo -nitrile as an examplary preferred compound; Alzheimer's and Parkinson's diseases; neuroprotectors; schizophrenia, analgesics; anxiolytic agents; respiratory disorders HOFFMAN-LA ROCHE INC. 2003-07-01 US disclosed